Japan’s pharma industry, a global innovation leader, faces strain from shifting demand, supply vulnerabilities, and digital disruption. Eight priorities can position it to lead in operations.
Anonymous readers can preview up to 1024 characters here. Log in to unlock the full article once ingest succeeds.